FAQ Library
Respected thought leaders answer frequently asked questions on issues important to your practice – available in video, audio, and transcript formats.
| Expert Commentary Subcutaneous Administration of Bortezomib Sandra E. Kurtin, RN, MS, AOCN®, ANP-C |
| Patient Care Tool Quick Reference: Symptom Management Throughout Stem Cell Transplant |
| CE Activity Novel Approaches for the Management of Elderly and Infirm Multiple Myeloma Patients Antonio Palumbo, MD, and Sandra E. Kurtin, RN, MS, AOCN®, ANP-C |
| CE Activity Advances in Consolidation, Stem Cell Collection, and Transplantation Sergio A. Giralt, MD, and Beth Faiman, RN, MSN, APRN-BC, AOCN® |
| FAQ Library How can you ensure patients are reporting side effects? Robert Z. Orlowski, MD, PhD |
| FAQ Library What is the CyBorD regimen's safety and efficacy as a primary therapy? Robert Z. Orlowski, MD, PhD |
| Clinical Trials New Clinical Trials for Relapsed/refractory |
| Journal Club Library Four abstracts posted for April |